-
381
Estimation of Apolipoprotein A1, Haptoglobin and Alpha 2macroglobulin with some Biochemical Metabolic Markers in Nonalcoholic Fatty Liver Disease Iraqi Patients
Published 2021-03-01Subjects: “…nonalcoholic fatty liver disease (NAFLD)…”
Get full text
Article -
382
Ethyl Lactate Ameliorates Hepatic Steatosis and Acute‐on‐Chronic Liver Injury in Alcohol‐Associated Liver Disease by Inducing Fibroblast Growth Factor 21
Published 2025-02-01Subjects: “…alcohol‐associated liver disease…”
Get full text
Article -
383
Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study
Published 2024-01-01“…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder in western countries. …”
Get full text
Article -
384
Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
Published 2017-01-01“…Nonalcoholic fatty liver disease (NAFLD) has become a leading cause of liver transplantation. …”
Get full text
Article -
385
Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study
Published 2021-01-01“…Previous studies have suggested a link between Helicobacter pylori (H. pylori) infection and nonalcoholic fatty liver disease (NAFLD), yet long-term follow-up studies to elucidate this association are lacking. …”
Get full text
Article -
386
-
387
Hepatocyte Growth Factor in Patients with Three Different Stages of Chronic Liver Disease including Hepatocellular Carcinoma, Cirrhosis and Chronic Hepatitis: An Immunohistochemical Study
Published 2001-01-01“…BACKGROUND AND AIMS: The specific role of hepatocyte growth factor in liver disease is unknown. The presence and density of this factor in patients with three different stages of liver disease were investigated, with the aim of assessing its prognostic significance.…”
Get full text
Article -
388
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
Published 2019-01-01“…Nonalcoholic fatty liver disease (NAFLD) is increasingly common among patients with type 2 diabetes mellitus (T2DM). …”
Get full text
Article -
389
Association between prognostic nutritional index and all-cause mortality and cardiovascular disease mortality in American adults with non-alcoholic fatty liver disease
Published 2025-02-01“…BackgroundThe current research was to investigate the relationship between prognostic nutritional index (PNI) and mortality, with a focus on all-cause and cardiovascular disease (CVD) mortality, for those with non-alcoholic fatty liver disease (NAFLD).MethodsData from 20,142 patients who participated in the National Health and Nutrition Examination Survey (NHANES), which was carried out between 2005 and 2014, were included in this research. …”
Get full text
Article -
390
Impact of remnant cholesterol on acute ischemic stroke prognosis: a nationwide cohort analysis stratified by non-alcoholic fatty liver disease status
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
391
Non-invasive methods for diagnosing portal hypertension and variceal bleeding due to liver cirrhosis secondary to NAFLD/MASLD: systematic review
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
392
Nutritional assessment using subjective global assessment identifies energy malnutrition and predicts mortality in patients with liver cirrhosis
Published 2025-02-01Subjects: “…Chronic liver disease…”
Get full text
Article -
393
The Role of Sulfatides in Liver Health and Disease
Published 2025-01-01Subjects: Get full text
Article -
394
Protective mechanism of Coprinus comatus polysaccharide on acute alcoholic liver injury in mice, the metabolomics and gut microbiota investigation
Published 2024-01-01Subjects: Get full text
Article -
395
-
396
Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPARγ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease
Published 2014-01-01“…The description and characterization of the toxicological MoA leading to non-alcoholic fatty liver disease (NAFLD) are of specific interest, due to its increasing incidence in the modern society. …”
Get full text
Article -
397
Therapeutic Effects of Milk Thistle (Silybum marianum L.) and Artichoke (Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats
Published 2022-01-01“…At present, nonalcoholic fatty liver disease (NAFLD) does not have an approved pharmacologic therapy. …”
Get full text
Article -
398
Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial
Published 2025-02-01“…Abstract Metabolic Associated Fatty Liver Disease (MAFLD) is becoming a major global health concern due to its links with obesity, insulin resistance, and cardiovascular risk. …”
Get full text
Article -
399
Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors
Published 2012-04-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
400
Prevalence and Clinical Spectrum of Liver Disease in Nepalese HIV-Sero-Positive Patients Undergoing Antiretroviral Therapy: A Cross-Sectional Hospital Based Study
Published 2017-01-01“…The present study sheds light on prevalence and clinical spectrum of liver disease in Nepalese HIV-sero-positive patients. …”
Get full text
Article